Retinal Damage in Multiple Sclerosis Disease Subtypes Measured by High-Resolution Optical Coherence Tomography von Schippling, Sven, Oberwahrenbrock, Timm, Ringelstein, Marius, Kaufhold, Falko, Zimmermann, Hanna, Keser, Nazmiye, Young, Kim Lea, Harmel, Jens, Hartung, Hans-Peter, Martin, Roland, Paul, Friedemann, Aktas, Orhan, Brandt, Alexander U.

Volltext

Adding to the Burden: Gastrointestinal Symptoms and Syndromes in Multiple Sclerosis von Levinthal, David J., Rahman, Ambreen, Nusrat, Salman, O’Leary, Margie, Heyman, Rock, Bielefeldt, Klaus

Volltext

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial von Hawker, Kathleen, O'Connor, Paul, Freedman, Mark S., Calabresi, Peter A., Antel, Jack, Simon, Jack, Hauser, Stephen, Waubant, Emmanuelle, Vollmer, Timothy, Panitch, Hillel, Zhang, Jiameng, Chin, Peter, Smith, Craig H.

Volltext

Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation von Darlington, Peter J., Touil, Tarik, Doucet, Jean-Sebastien, Gaucher, Denis, Zeidan, Joumana, Gauchat, Dominique, Corsini, Rachel, Kim, Ho Jin, Duddy, Martin, Jalili, Farzaneh, Arbour, Nathalie, Kebir, Hania, Chen, Jacqueline, Arnold, Douglas L., Bowman, Marjorie, Antel, Jack, Prat, Alexandre, Freedman, Mark S., Atkins, Harold, Sekaly, Rafick, Cheynier, Remi, Bar-Or, Amit

Volltext

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial von Cadavid, Diego, Mellion, Michelle, Hupperts, Raymond, Edwards, Keith R, Calabresi, Peter A, Drulović, Jelena, Giovannoni, Gavin, Hartung, Hans-Peter, Arnold, Douglas L, Fisher, Elizabeth, Rudick, Richard, Mi, Sha, Chai, Yi, Li, Jie, Zhang, Yiwei, Cheng, Wenting, Xu, Lei, Zhu, Bing, Green, Susan M, Chang, Ih, Deykin, Aaron, Sheikh, Sarah I, Agüera Morales, Eduardo, Al Khedr, Abdullatif, Ampapa, Radek, Arroyo, Rafael, Belkin, Martin, Bonek, Robert, Boyko, Alexey, Capra, Ruggero, Centonze, Diego, Clavelou, Pierre, Debouverie, Marc, Drulovic, Jelena, Edwards, Keith, Evangelou, Nikos, Evdoshenko, Evgeniy, Fernández, Oscar, Fernández Sánchez, Victoria, Freedman, Mark, Freedman, Steven, Fryze, Waldemar, Garcia-Merino, Antonio, Gavric-Kezic, Mira, Ghezzi, Angel, Gout, Olivier, Grimaldi, Luigi, Hertmanowska, Hanka, Hintzen, Rogier, Hradilek, Pavel, Hupperts, Raymond, Ilkowski, Jan, Ivashinenkova, Evelina, Izquierdo, Guillermo, Jacques, Francois, Jakab, Gabor, Khabirov, Farit, Klodowska-Duda, Gabriela, Komoly, Samuel, Kostic, Smiljana, Kovarova, Ivana, Kremenchuzky, Marcelo, Laganke, Christopher, LaPierre, Yves, Maciejowski, Maciej, Maison, Francois Grand, Marfia, Girolama Alessandra, Martínez Yélamos, Sergio, Meluzinova, Eva, Montalban, Xavier, Murray, Ronald, Naismith, Robert, Newsome, Scott, Nguyen, Viet, Oreja, Delia, Pardo, Gabriel, Pasechnik, Elena, Patti, Francesco, Potemkowski, Andrzej, Prokopenko, Semen, Qian, Peiqing, Rodríguez-Antigüedad, Alfredo, Rossman, Howard, Rozsa, Csilla, Sánchez López, Fernando, Selmaj, Krzysztof, Silber, Eli, Stepien, Adam, Stepniewska, Anna, Swiat, Maciej, Toncev, Gordana, Tourbah, Ayman, Trushnikova, Tatyana, Uccelli, Antonio, Vachova, Marta, Valis, Martin, Vecsei, Laszlo, Wiertlewski, Sandrine, Zaffaroni, Mauro, Zielinski, Tomasz

Volltext

The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group von Freedman, Mark S, Bar-Or, Amit, Atkins, Harold L, Karussis, Dimitrios, Frassoni, Francesco, Lazarus, Hillard, Scolding, Neil, Slavin, Shimon, Le Blanc, Katarina, Uccelli, Antonio

Volltext

MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): a randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of m... von Uccelli, Antonio, Laroni, Alice, Brundin, Lou, Clanet, Michel, Fernandez, Oscar, Nabavi, Seyed Massood, Muraro, Paolo A, Oliveri, Roberto S, Radue, Ernst W, Sellner, Johann, Soelberg Sorensen, Per, Sormani, Maria Pia, Wuerfel, Jens Thomas, Battaglia, Mario A, Freedman, Mark S

Volltext

Cell-based therapeutic strategies for multiple sclerosis von Scolding, Neil J, Pasquini, Marcelo, Reingold, Stephen C, Cohen, Jeffrey A

Volltext

Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders von Ciccarelli, Olga, Cohen, Jeffrey A, Reingold, Stephen C, Weinshenker, Brian G, Amato, Maria Pia, Banwell, Brenda, Barkhof, Frederik, Bebo, Bruce, Becher, Burkhard, Bethoux, François, Brandt, Alexander, Brownlee, Wallace, Calabresi, Peter, Chatway, Jeremy, Chien, Claudia, Chitnis, Tanuja, Ciccarelli, Olga, Cohen, Jeffrey, Comi, Giancarlo, Correale, Jorge, De Sèze, Jerome, De Stefano, Nicola, Fazekas, Franz, Flanagan, Eoin, Freedman, Mark, Fujihara, Kazuo, Galetta, Steven, Goldman, Myla, Greenberg, Benjamin, Hartung, Hans-Peter, Hemmer, Bernhard, Henning, Anke, Izbudak, Izlem, Kappos, Ludwig, Lassmann, Hans, Laule, Cornelia, Levy, Michael, Lublin, Fred, Lucchinetti, Claudia, Lukas, Carsten, Marrie, Ruth Ann, Miller, Aaron, Miller, David, Montalban, Xavier, Mowry, Ellen, Ourselin, Sebastien, Paul, Friedemann, Pelletier, Daniel, Ranjeva, Jean-Philippe, Reich, Daniel, Reingold, Stephen, Rocca, Maria Assunta, Rovira, Alex, Schlaerger, Regina, Soelberg Sorensen, Per, Sormani, Maria, Stuve, Olaf, Thompson, Alan, Tintoré, Mar, Traboulsee, Anthony, Trapp, Bruce, Trojano, Maria, Uitdehaag, Bernard, Vukusic, Sandra, Waubant, Emmanuelle, Weinshenker, Brian, Wheeler-Kingshott, Claudia Gandini, Xu, Junqian

Volltext

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial von Goodman, Andrew D, Prof, Brown, Theodore R, MD, Krupp, Lauren B, MD, Schapiro, Randall T, MD, Schwid, Steven R, MD, Cohen, Ron, MD, Marinucci, Lawrence N, MS, Blight, Andrew R, PhD

Volltext

Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects von Cohen, Jeffrey A, Prof, Reingold, Stephen C, PhD, Polman, Chris H, Prof, Wolinsky, Jerry S, Prof

Volltext

A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper von Saccardi, R, Freedman, MS, Sormani, MP, Atkins, H, Farge, D, Griffith, LM, Kraft, G, Mancardi, GL, Nash, R, Pasquini, M, Martin, R, Muraro, PA

Volltext

Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients von Giovannoni, Gavin, Cohen, Jeffrey A, Coles, Alasdair J, Hartung, Hans-Peter, Havrdova, Eva, Selmaj, Krzysztof W, Margolin, David H, Lake, Stephen L, Kaup, Susan M, Panzara, Michael A, Compston, D. Alastair S

Volltext

When to Initiate Disease-Modifying Drugs for Relapsing Remitting Multiple Sclerosis in Adults? von Alkhawajah, Mona, Oger, Joel

Volltext

Intravenous immunoglobulin in relapsing-remitting multiple sclerosis : A dose-finding trial von FAZEKAS, F, LUBLIN, F. D, LI, D, FREEDMAN, M. S, HARTUNG, H. P, RIECKMANN, P, SOELBERG SØRENSEN, P, MAAS-ENRIQUEZ, M, SOMMERAUER, B, HANNA, K

Volltext

Antibody dissociation rates are predictive of neutralizing antibody (NAb) course: A comparison of interferon beta-1b-treated Multiple Sclerosis (MS) patients with transient versus... von Gibbs, Ebrima, Karim, Mohammad Ehsanul, Oger, Joel

Volltext

Late Detachment of Descemet's Membrane After Subconjunctival THC:YAG (Holmium) Laser Thermal Sclerostomy Ab Externo von Wong, Vernon K.W., Koenig, Steven B., Fogel, Erin S., Freedman, Mark I.

Volltext

Effects of interferon beta-1b on cognitive performance in patients with a first event suggestive of multiple sclerosis

Volltext bestellen

What does serum neurofilament light chain (SNFL) tell us about clinical disease von Freedman, Mark

Volltext

Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis von Thebault, Simon, Abdoli, Mohammad, Fereshtehnejad, Seyed-Mohammad, Tessier, Daniel, Tabard-Cossa, Vincent, Freedman, Mark S.

Volltext